# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-02-05 | **更新时间**: 09:20 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- `[06:31]` **溶瘤病毒临床试验格局势头强劲：100 多家公司引领新疗法的开拓 |深入洞察**
  <br><small>🇬🇧 *Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight* [🔗Source](https://news.google.com/rss/articles/CBMikgJBVV95cUxOQTR0d1l3a3B2VmdFdjY0QkJVZ01rYmtPV0gtNERtMXMyN1lXdTdpOTFRRjFjREFaSENvbDByU2JUdzRVZ2Mxc3dsbU8zYm5MUElhVGl3RHkyU3NzaTZ5b3U2T1NOUGlUaE90MDNtUTB1Z2xIeWRSZ1NfTEpwU1hzcDZiZnpYX0puU1lTZmYyMDZ6YS02YnowdU1jbU1wZmh0d3pYNmpiYV9VVnpzTXRva09wdE9RUzZ1d3dWOGtVMGJwVmFaVkJndlJMM09oSWRhUWZKVUJJSW1iSXBWc0p5bm83ZlZOYmxaZXdEOG1ZZHZib2pxcUltWmFrdjJha0JhRFNKYTF3QlFjd0hEN29VTVJB?oc=5)</small>
- `[22:00]` **Arcellx 宣布在 TANDEM 上发表最新演讲，展示 anito-cel 的 D 域结合剂的独特、高目标特异性**
  <br><small>🇬🇧 *Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel’s D-Domain Binder* [🔗Source](https://news.google.com/rss/articles/CBMilAJBVV95cUxPMTZaMl9ycjF4MXRja1U0cXB5U01CbjZNQTdaaDZTLXdtajZTVWxVZ2lEU1Y4MmxXQ1EtUlhnX2FqN3VyMEx4UXlSYjhnMkZEMWlFelBIa3BEc0c1ZlJWcm9neVQ2NlR0VXhSb1dzdFJyYThrVFZVT3U1Zzd6bEI1czNxenJMZWhxMEx6OE1BVW0wWE9LSmNGTy15WDZaQWlWRHFPUzRhR2RCN3BhZTRCZE05TUJJUkRXTTE1ZjhSR0NJTGIzYzlBdUxKc1B4dUJaMWRTWnNSbFZHUkhnQjBJMTZVc3Y3RV82OTVKalZLU0JMTW5EV2NuZ2toNWVlV00xaU1ndXd0aW9MYm4tS1JYUWE4d2k?oc=5)</small>
- `[21:00]` **Tr1X 展示首个临床数据，证明同种异体现成 Tr1 调节性 T 细胞疗法 TRX103 的安全性和机制证明**
  <br><small>🇬🇧 *Tr1X Presents First Clinical Data Demonstrating Proof of Safety and Proof of Mechanism With Allogeneic Off-the-Shelf Tr1 Regulatory T Cell Therapy TRX103* [🔗Source](https://news.google.com/rss/articles/CBMitAJBVV95cUxQMGRrRTE4OF9PclZWUEdreC1vNGhGMURrVFdkTEVjWXkxX09NU2dNdk5LRThoSVdMU1hkUU5MQWhmcjdaNWpKMlNac0VvMklRZmdBZ1hDb2N4cU9rNlBXTmdMUUJvSEpwc3VWdFNzVF9EeUNCZnFpaUFXb2o3TG1CanptZlIzeUdSMFZFUlJRUHBBUTZ1a0NFR2RtU0ZGX2dvYUNHb1FMTjM0emh5TTNZSnFxYXhSVVQ3d3dZYTY3XzFlY2tHYno3aHdfc29qZHVqS3pjTXpqSDRLMEFXNDA3dnBhdlFZbjFBY21UYldHQmF4bHhXcVlTaWJvd1RPQy14OHlGdzdMSllMazV0MHN3Nm1xMXJDazVrRjQyWkprY1Y3a09fWUxiU3g2NUpFekV5b1I1bw?oc=5)</small>
- `[20:00]` **BirchBioMed 外用乳膏获得加拿大卫生部批准 (NPN 80147114)**
  <br><small>🇬🇧 *BirchBioMed Receives Health Canada Approval for Topical Cream (NPN 80147114)* [🔗Source](https://news.google.com/rss/articles/CBMiygFBVV95cUxPcXVqblFUNWZicVhlVmZseVlPbDBQeFBoZXBDOGk5dURfeWpULUY5NnV0UDFJV3YzUGsyMDhRdng4Q01vRU9CdVpWcFZLYTdiaVFoWWhFaWRnQ3RMUWZDaV9PM3h5cVdIeFRaRUkzNjFZcy1rV2FYeFRRaHh2VnhpZUNmZTVjWVkzdGxGNzhHSUM3b1pDZVZwaHB0c21Qcy1yOXpWY08yZ1FtR2NIbHVUVktBb2R1VFJTU20wQ1YyZXduZzBBQVZhOHhn?oc=5)</small>

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[05:57]` **Tempest Therapeutics完成CAR-T资产收购 提供者 Investing.com** [🔗阅读原文](https://news.google.com/rss/articles/CBMicEFVX3lxTE9OUzNYbGw5RVA0bGR5WUdycWpLMWdqTGJpUXA4aEZPRnNIQzJzMEZTaXNHSXVSNWdzZnhOMThQQkVmUlNTcnhQdGMxRFhQS3VPYzBqQl9vTnV1WWVrNW0yOWV1RUJwVnlJNEt2VWR4aEQ?oc=5)
- `[05:47]` **Tempest 宣布完成双靶点 CAR-T 资产战略收购**
  <br><small>🇬🇧 *Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets* [🔗Source](https://news.google.com/rss/articles/CBMi6AFBVV95cUxPcUJNNldSTkphbTBUMk1NUGdPRG1UVWljckxKRmxTcDMzWkI1Q3p0OVpIMk9pNkF2RU5SQWN0RmFFVUFvQklyRXJLYU40MzhJWW9pOVhJTFBnT29ZVm9WdHpwVXVxUzRVc295MDMwdDMzSE9JdFphXzZqb0J3S0xrQ1JudUZ3QmluLXZUWnBvTXcyQ19Dakx6M3NTRTZqdEVGaHkwWEdxNnR2aHNvalpkT0Z6LWRRMXRpRXI3cDB2NFpQYUZhYWdncDBIUTNoRGl6R3V0T1pYajZjczczREQwajh6V051d2lU?oc=5)</small>
- `[11:20]` **Medipost 的 CARTISTEM 获得美国 3 期临床试验 IND 批准**
  <br><small>🇬🇧 *Medipost’s CARTISTEM Receives U.S. Phase 3 Clinical Trial IND Approval* [🔗Source](https://news.google.com/rss/articles/CBMidEFVX3lxTE5nSlpHdXE2SzdVU0g5cGd3UFFBNVRXaHFDVmdyQTJqc2pjbmQwQ1p6NVJCWDBNNTdaLUx5M19ONk90RE41ZjNaN1Y4VjNRWk9XTElLM1NNTUpVTkNqb2JERVlBOGtPN21WemY4cm40TTdVeEVU?oc=5)</small>
- `[11:12]` **西湖云谷智药团队联合开发人T细胞靶向的AAV-M2变体，单针介导的体内CAR-T疗法实现红斑狼疮的免疫重置** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTFB6WGRFV0ROU0tzcjV0T1hqU3VuVTBDMkFtWlZ3YTdVSFJsTGJSQlRSU0hpeVRvN1RBMzRhbWJZV0ItbmJ6ZWNEVExNMzVHOE0yTUwtRFRsbWNnS1JQajBaeFZQUkJvYk5LQ1NCZkw1aERKRkp4UnJLY1piU3NiZw?oc=5)
